Affiliation:
1. Amity University Noida
2. Sharda University
3. King Saud University
Abstract
Abstract
Psoriasis (PSO) is a chronic immune-mediated skin condition characterized by abnormal keratinocyte growth and inflammation. Clinical occurrences have hinted to a potential connection between fungi and psoriasis as several Malassezia species and Candida Albicans species have been linked to distinct psoriasis subtypes. Triazoles Antifungal drugs have been used mainly to treat Fungal diseases. In this study, we intend to find out different target mechanism pathway through which triazoles drugs can act in the pathophysiology of psoriasis by Network pharmacology approach. Utilizing Swiss Target Prediction, GeneCard, Pharmmapper, Venn diagram analysis, String database, and Cytoscape, the study identified 76 mutual targets out of 4492 for psoriasis and 294 for triazole derivatives. The PPI network highlighted core targets such as CASP3, CCL5, SRC, PPARG, STAT1, MMP9, EGFR, IL2, ESR1, and AKT1. KEGG pathway enrichment analysis unveiled relevant pathways, including proteoglycans in cancer and Th17 cell differentiation. The network pharmacology study and molecular docking method shows multi-target pathway mechanism of triazole antifungal drugs.
Publisher
Research Square Platform LLC
Reference35 articles.
1. Pathogenesis and therapy of psoriasis;Lowes MA;Nature,2007
2. The cytokine mediated molecular pathophysiology of psoriasiss and its clinical implications;Singh R;Int. J. Mol. Sci.,2021
3. A Review of Existing Therapies and Recent Advances in Treatment Spontaneous Bacterial Peritonitis View project Pharmacovigilance View project Psoriasis: A Review of Existing Therapies and Recent Advances in Treatment;Dutta S;J Ration. Pharmacother Res,2018
4. Roles of Infection in Psoriasis;Zhou S;Int. J. Mol. Sci.,2022
5. The Clinical Pharmacokinetics of Itraconazole: An Overview;Heykants J;Mycoses,1989